IRIS - Res&Arch Institutional Research Information System - Research & Archive

VELARDI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.303
EU - Europa 4.837
AS - Asia 4.557
SA - Sud America 755
AF - Africa 126
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.170
SG - Singapore 2.092
IT - Italia 803
IE - Irlanda 785
CN - Cina 648
UA - Ucraina 625
RU - Federazione Russa 602
SE - Svezia 595
BR - Brasile 586
HK - Hong Kong 582
VN - Vietnam 481
FI - Finlandia 319
DE - Germania 318
FR - Francia 273
GB - Regno Unito 189
KR - Corea 164
BD - Bangladesh 125
IN - India 107
TR - Turchia 67
CA - Canada 62
AR - Argentina 57
IQ - Iraq 51
PL - Polonia 46
NL - Olanda 45
MX - Messico 43
ZA - Sudafrica 41
CH - Svizzera 39
AT - Austria 36
BE - Belgio 32
UZ - Uzbekistan 30
PK - Pakistan 28
CZ - Repubblica Ceca 26
JP - Giappone 26
CO - Colombia 25
RO - Romania 25
EC - Ecuador 24
ID - Indonesia 23
SA - Arabia Saudita 22
PH - Filippine 21
ES - Italia 18
VE - Venezuela 18
GR - Grecia 17
BO - Bolivia 13
EG - Egitto 13
JO - Giordania 13
MA - Marocco 13
TN - Tunisia 12
CL - Cile 11
KE - Kenya 10
LT - Lituania 10
PE - Perù 10
LB - Libano 9
IL - Israele 8
MY - Malesia 8
PY - Paraguay 8
DZ - Algeria 7
OM - Oman 7
AZ - Azerbaigian 6
ET - Etiopia 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
NP - Nepal 5
AU - Australia 4
BG - Bulgaria 4
DK - Danimarca 4
EU - Europa 4
GE - Georgia 4
JM - Giamaica 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
DO - Repubblica Dominicana 3
HN - Honduras 3
HR - Croazia 3
LV - Lettonia 3
ML - Mali 3
NG - Nigeria 3
QA - Qatar 3
AL - Albania 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
EE - Estonia 2
GT - Guatemala 2
KG - Kirghizistan 2
MK - Macedonia 2
MU - Mauritius 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
TJ - Tagikistan 2
TW - Taiwan 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DJ - Gibuti 1
Totale 16.562
Salva come PNG Salva come JPEG
Città #
Singapore 1.520
Dublin 785
Chandler 741
San Mateo 604
Hong Kong 579
San Jose 566
Ashburn 416
Jacksonville 325
Boardman 318
Perugia 290
Santa Clara 243
Moscow 204
Dong Ket 178
Medford 176
Princeton 175
Altamura 168
Beijing 167
Lauterbourg 163
Seoul 159
Ann Arbor 147
Wilmington 137
Lawrence 127
Andover 120
Ho Chi Minh City 105
Los Angeles 104
Munich 98
Helsinki 94
New York 93
The Dalles 70
Piscataway 68
Turku 64
Hanoi 63
São Paulo 55
Des Moines 49
Saint Petersburg 49
Norwalk 48
Frankfurt am Main 42
Shanghai 37
Orem 35
Woodbridge 32
Houston 29
Brooklyn 28
Johannesburg 28
London 28
Brussels 27
Izmir 27
Rome 27
Warsaw 27
San Paolo di Civitate 26
Redmond 25
Tokyo 25
Dallas 24
Stockholm 24
Amsterdam 23
Atlanta 22
Baghdad 22
Boston 21
Phoenix 20
Rio de Janeiro 20
Bucharest 19
Chennai 19
Falls Church 19
Montreal 19
Nuremberg 19
Brno 18
Chicago 18
San Francisco 18
Denver 17
Hefei 17
Dearborn 16
Milan 16
Falkenstein 15
Vienna 15
Belo Horizonte 14
Da Nang 14
Tashkent 14
Auburn Hills 13
Bologna 13
Espoo 13
Florence 13
Foligno 13
Guangzhou 13
Quito 13
Toronto 13
Brasília 12
Columbus 12
Manchester 12
New Delhi 12
Redwood City 12
Curitiba 11
Dhaka 11
Medellín 11
Prata Di Pordenone 11
Council Bluffs 10
Mumbai 10
Riyadh 10
Terni 10
Tianjin 10
Barnet 9
Can Tho 9
Totale 10.450
Salva come PNG Salva come JPEG
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 187
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 182
Innate immunity against hematological malignancies 163
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 156
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 147
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 140
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 139
14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation. 138
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 130
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 129
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation 127
Fourth international workshop on haploidentical transplants, Naples, Italy 126
Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk 126
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 125
"Designed" grafts for HLA-haploidentical stem cell transplantation. 124
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. 124
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 123
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 123
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 123
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 122
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 121
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 121
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 121
T helper 2 antagonists restore antifungal T helper immunity in mice with T cell-depleted bone marrow transplantation 120
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 120
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 120
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 120
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 119
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 118
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 117
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 116
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 116
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 115
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 114
CMV management with specific immunoglobulins: A multicentric retrospective analysis on 92 allotransplanted patients 113
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 113
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism 112
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 111
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 110
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 108
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 107
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 106
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 106
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 105
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 105
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 105
Increased Ratio of CD31+/CD42- Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia. 105
Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation 105
Allogeneic transplantation across the HLA barriers. 105
Transplants across human leukocyte antigen barriers 104
16th IHIW: international histocompatibility working group in hematopoietic cell transplantation. 103
. Mismatched hematopoietic stem cell transplants in elderly patients. 103
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 102
Natural killer cell alloreactivity for leukemia therapy. 101
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 100
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors 99
The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. . 99
Allogenic and autologous transplantation for haematological diseases, solid tumours and immune disorders:current practice in europe 2009. 99
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 98
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 98
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 97
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 97
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 97
Non-MHC-restricted cytotoxic cells: Their roles in the control and treatment of leukaemias 96
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 96
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 96
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 96
Total Marrow/Total Lymphoid Irradiation as Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients 96
Cellular therapy: exploiting NK cell alloreactivity in transplantation 95
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation 95
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 95
Natural killer cells: biology and application in stem-cell transplantation 94
Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation 94
Haploidentical stem cell transplantation for acute leukemia 93
T cells expressing chimeric antigen receptor promote immune tolerance 93
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 93
TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 93
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 92
Natural killer cell-mediated lysis of autologous cells modified by gene therapy 92
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 92
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 92
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 91
Mismatched hematopoietic stem cell transplantation in secondary leukemia 91
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation 91
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 91
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 91
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 91
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 90
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells. 90
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 90
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. 90
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: A retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 89
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 88
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. 88
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants 88
Foxp3+regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesis 88
Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia 87
New mechanism of lymphoma-induced bone marrow aplasia 87
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 86
Differences in Aspergillus-specific immune recovery between T-cell-replete and T-cell-depleted hematopoietic transplants 86
Totale 10.811
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 0 0 203
2021/20221.820 34 486 63 120 77 13 24 491 9 53 230 220
2022/20232.542 193 498 21 188 177 257 5 115 957 10 94 27
2023/20241.124 58 120 43 20 7 19 240 21 120 31 198 247
2024/20252.628 57 270 87 128 362 88 73 187 492 151 488 245
2025/20265.890 407 367 328 733 777 561 976 311 638 520 176 96
Totale 17.005